摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-propylnonan-5-amine

中文名称
——
中文别名
——
英文名称
5-propylnonan-5-amine
英文别名
5-Propylnonan-5-amine
5-propylnonan-5-amine化学式
CAS
——
化学式
C12H27N
mdl
——
分子量
185.353
InChiKey
BYTBWZAWFBLOEO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    13
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    26
  • 氢给体数:
    1
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    5-壬酮 在 lithium aluminium tetrahydride 、 sodium azide 、 三氟乙酸 作用下, 以 乙醚二氯甲烷 为溶剂, 反应 33.0h, 生成 5-propylnonan-5-amine
    参考文献:
    名称:
    以伯叔烷基胺为基石的方法
    摘要:
    初级叔烷基胺包括金刚烷胺的类似物,通常连接到药效基团的片段,以提高生物活性。伯叔烷基胺的制备被认为是一个难题。四个合成步骤,其中一些已经用于与胺的合成已有报道初级(RCH 2 NH 2)或仲(RR'CHNH 2)烷基和/或芳基,伯合成进行了测试叔烷基胺(RR'R''CNH 2)包括金刚烷加合物在内的脂族系列。这些程序包括在形成和还原的叔烷基叠氮化物,在标准和改良条件Ritter反应,在加入有机金属试剂以ñ -叔丁基亚磺酰基酮亚胺和一锅在路易斯酸的存在下,Τi(IPRO)腈和有机金属试剂之间的反应4或CeCl 3.对于伯叔烷基胺,尚未开发这些合成途径。当前缺乏对伯叔烷基胺的合成路线的研究。研究了每种方法的反应条件和底物限制,第一种方法是最通用的方法,也适用于带有大分子加合物的化合物。
    DOI:
    10.1016/j.tet.2019.06.016
点击查看最新优质反应信息

文献信息

  • Method for producing allyl compound, and ether or ester compound produced thereby
    申请人:MITSUBISHI CHEMICAL CORPORATION
    公开号:US20040147757A1
    公开(公告)日:2004-07-29
    A method for producing an allyl compound having a compositional formula different from that of an allyl starting material compound, which comprises reacting the allyl starting material compound with an oxygen nucleophilic agent in the presence of a catalyst containing at least one transition metal compound containing a transition metal selected from the group consisting of transition metals belonging to Group 8 to Group 10 of the Periodic Table and a multidentate phosphite compound.
    一种生产具有与烯丙基起始物质化合物不同的组成式的烯丙基化合物的方法,包括在存在至少一种含有从周期表第8组到第10组的过渡金属属于的过渡金属的过渡金属化合物和多齿膦酸酯化合物的催化剂的情况下,将烯丙基起始物质化合物与氧亲核试剂反应。
  • [EN] DUAL CLK/CDK1 INHIBITORS FOR CANCER TREATMENT<br/>[FR] INHIBITEURS DOUBLES DE CLK/CDK1 DESTINÉS AU TRAITEMENT DU CANCER
    申请人:STANFORD RES INST INT
    公开号:WO2018064545A1
    公开(公告)日:2018-04-05
    This disclosure generally relates to dual CLK2/CDK1 inhibitors or more potent and specific CLK inhibitors to target CLK2 and CDKl kinases in the treatment of germ-line mutations of the spliceosome leading to the development of cancers and other human disease. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    本公开一般涉及双重CLK2/CDK1抑制剂或更强效、更特异的CLK抑制剂,用于治疗导致癌症和其他人类疾病发展的剪接体的生殖细胞系突变。本摘要旨在作为在特定领域进行搜索的扫描工具,不打算限制本发明。
  • Method for producing allyl compound
    申请人:MITSUBISHI CHEMICAL CORPORATION
    公开号:US20040092777A1
    公开(公告)日:2004-05-13
    A method for producing an allyl compound having a compositional formula different from that of an allyl starting material compound, which comprises reacting the allyl starting material compound with an oxygen nucleophilic agent having a structure different from that of the allyl starting material compound in the presence of a catalyst containing at least one transition metal compound containing a transition metal selected from the group consisting of transition metals belonging to Group 8 to Group 10 of the Periodic Table and a monodentate phosphite compound having a structure of the following formula (1): P(OR 1 )(OR 2 )(OR 3 )   (1) wherein R 1 , R 2 and R 3 are respectively independently an alkyl group which may have a substituent, carbon chains of R 1 , R 2 and R 3 may have at least one carbon-carbon double bond or triple bond, and at least two optional groups of R 1 , R 2 and R 3 may bond to each other to form at least one cyclic structure.
    一种制备具有与烯丙基起始材料化合物不同组成式的烯丙基化合物的方法,包括在至少包含选择自周期表8至10族过渡金属的过渡金属化合物和具有以下式(1)结构的单齿磷酸酯化合物催化剂存在下,将烯丙基起始材料化合物与具有不同于烯丙基起始材料化合物的结构的氧亲核试剂反应,其中式(1)中,R1、R2和R3分别独立地是可以具有取代基的烷基,R1、R2和R3的碳链可以具有至少一个碳-碳双键或三键,并且R1、R2和R3的至少两个可选基团可以结合形成至少一个环状结构。
  • [EN] INFRARED ABSORBING COMPOUNDS AND THEIR USE IN IMAGEABLE ELEMENTS<br/>[FR] COMPOSES ABSORBEURS D'UV ET LEUR UTILISATION DANS DES ELEMENTS IMAGEABLES
    申请人:KODAK POLYCHROME GRAPHICS LLC
    公开号:WO2004069938A1
    公开(公告)日:2004-08-19
    Infrared absorbing compounds in which both the anion and the cation absorb infrared radiation, imageable elements that contain these compounds, and methods for forming images using the imageable elements are disclosed. The compounds have the structure (I) and (II) in which Y1 and Y2 are each independently hydrogen, halo, alkyl, diphenylamino, or phenylthio; R1, R2, R3 and R4 are each independently hydrogen, methyl, or SO3-, with the proviso that two fo R1, R2, R3, and R4 are SO3-; R5 and R6 are each independently an alkyl group; Z1, Z2, Z4 and Z5 are each independently a benzo group or a nophtho group; Z3 and Z6 are each independently two hydrogen atoms, a cyclohexene residue, or a cyclopentene residue; X1, X2, X3, and X4 are each independently S, O, NH, CH2, or C(CH3)2; and n1 and n2 are each independently 0 to 4.
    本发明涉及吸收红外辐射的化合物,其中阴离子和阳离子均吸收红外辐射,包含这些化合物的可成像元素以及使用可成像元素形成图像的方法。化合物具有结构(I)和(II),其中Y1和Y2分别独立地为氢、卤素、烷基、二苯胺或苯硫醚;R1、R2、R3和R4分别独立地为氢、甲基或SO3-,但其中两个为SO3-;R5和R6分别独立地为烷基;Z1、Z2、Z4和Z5分别独立地为苯并环或萘并环;Z3和Z6分别独立地为两个氢原子、环己烯残基或环戊烯残基;X1、X2、X3和X4分别独立地为S、O、NH、CH2或C(CH3)2;n1和n2分别独立地为0至4。
  • Method for producing allyl compound, and allyl compound produced thereby
    申请人:Takai Masaki
    公开号:US20050075518A1
    公开(公告)日:2005-04-07
    A method for producing an allyl compound having a compositional formula different from that of an allyl starting material compound, which comprises reacting the allyl starting material compound with a nucleophilic agent in the presence of a catalyst containing at least one transitional metal compound containing a transition metal selected from the group consisting of transition metals belonging to Group 8 to Group 10 of the Periodic Table and at least one bidentate coordinated phosphite compound selected from the group consisting of compounds having structures of the following formulae (I) to (III): wherein A 1 to A 3 are respectively independently a diarylene group having a branched alkyl group at the ortho-position, R 1 to R 6 are respectively independently an alkyl group which may have a substituent or an aryl group which may have a substituent (including a heterocyclic compound forming an aromatic 6π electron cloud on the upper and lower sides of the ring, hereinafter the same), and Z 1 to Z 3 are respectively independently an alkylene group which may have a substituent, an arylene group which may have a substituent, an alkylene-arylene group which may have a substituent or a diarylene group which may have a substituent.
    一种制备具有不同于烯丙基起始材料化合物的组成式的烯丙基化合物的方法,包括在催化剂的存在下,将烯丙基起始材料化合物与亲核试剂反应,所述催化剂包含至少一种过渡金属化合物,所述过渡金属选自周期表8到10组的过渡金属,并且至少一种双齿配位膦酸酯化合物,所述化合物具有以下式(I)到(III)中的结构,其中A1到A3分别独立地是具有支链烷基的二芳基基团,R1到R6分别独立地是可以具有取代基的烷基基团或可以具有取代基的芳基基团(包括在环上形成芳香6π电子云的杂环化合物,在此以后相同),Z1到Z3分别独立地是可以具有取代基的烷基,可以具有取代基的芳基,可以具有取代基的烷基-芳基基团或可以具有取代基的二芳基基团。
查看更多

同类化合物

(N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷 顺,顺-丙二腈 非那唑啉 靛酚钠盐 靛酚 霜霉威盐酸盐 霜脲氰